The GLP-1 Weight Loss Revolution | Form Health CEO Evan Richardson
GLP-1 drugs such as Ozempic and Wegovy have transformed best practices for weight loss care and created an opportunity for digital health innovation. In this episode, Steve Kraus sits down with Evan Richardson, founder and CEO of Form Health, to discuss GLP-1s and the virtual medical weight loss care landscape. We cover:
How Form Health differentiates itself in the competitive weight care market
The impact of GLP-1 medications and the challenges of drug shortages
The role of compounding pharmacies and potential regulatory changes
The importance of holistic care and patient adherence for sustainable weight loss
Obesity treatment innovation and the future of healthcare
Advice for aspiring healthcare entrepreneurs from his experiences at Castlight Health and Included Health
About our guest:
Evan Richardson is the founder and CEO of Form Health, the leader in science-based obesity care.
Evan founded Form Health in 2019 after a career working at the intersection of health tech and health tech investing. He saw an opportunity to leverage technology and recent weight loss-related pharmacological innovations to deliver evidence-based care that could meaningfully address the obesity epidemic.
Evan was drawn to health tech early in his career after working as an investor in the industry and recognizing the massive opportunity to make significant improvements to people’s lives. During this time, Evan became aware of an obesity care service connected to a major diabetes hospital. While its economic model didn’t work at the time, the company opened his eyes to the way evidence-based medical care could positively impact the lives of people living with obesity.
Evan began his career working at Bain & Company and Berkshire Partners. He got his start in health tech in 2011 when he became an early employee at Castlight, a healthcare navigator. As Head of Enterprise Products, Evan led the work building Castlight’s suite of enterprise-focused products including mobile, pharma, and insurer platforms. In 2013, Evan was a member of the founding team at Grand Rounds, a clinical navigator that later acquired telehealth provider Doctor on Demand to become Included Health. During his time at Grand Rounds, Evan held a variety of leadership roles across product, data science, operations, finance, and corporate development.
Evan currently serves on the boards of Bicycle Health, a virtual treatment provider for opioid dependence, and Crossover Health, a hybrid primary health care provider redesigning care delivery and cost models.
Evan has a degree in computer science from Dartmouth University and an MBA from Harvard Business School.
Listen